Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry.

Saved in:

Bibliographic Details
Title:	Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry.
Authors:	Conde, Esther¹, Suárez-Gauthier, Ana¹, Benito, Amparo², Garrido, Pilar², García-Campelo, Rosario³, Biscuola, Michele⁴, Paz-Ares, Luis⁴, Hardisson, David⁵, de Castro, Javier⁵, Camacho, M. Carmen⁶, Rodriguez-Abreu, Delvys⁶, Abdulkader, Ihab⁷, Ramirez, Josep⁸, Reguart, Noemí⁸, Salido, Marta⁹, Pijuán, Lara⁹, Arriola, Edurne⁹, Sanz, Julián¹⁰, Folgueras, Victoria¹¹, Villanueva, Noemí¹¹
Source:	PLoS ONE. Sep2014, Vol. 9 Issue 9, p1-9. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	19326203
DOI:	10.1371/journal.pone.0107200